• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type III.人Ⅲ型肽基精氨酸脱亚氨酶的结晶及初步X射线晶体学分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Jun 1;68(Pt 6):668-70. doi: 10.1107/S1744309112015333. Epub 2012 May 23.
2
Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type I.人I型肽基精氨酸脱亚氨酶的结晶及初步X射线晶体学分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Dec;69(Pt 12):1357-9. doi: 10.1107/S1744309113028704. Epub 2013 Nov 28.
3
Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase V.人肽基精氨酸脱亚氨酶V的结晶及初步X射线晶体学分析
Acta Crystallogr D Biol Crystallogr. 2003 Dec;59(Pt 12):2332-3. doi: 10.1107/s0907444903022741. Epub 2003 Nov 27.
4
Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.人肽基精氨酸脱亚氨酶 III 型的结构提供了对底物识别和抑制剂设计的深入了解。
Arch Biochem Biophys. 2021 Sep 15;708:108911. doi: 10.1016/j.abb.2021.108911. Epub 2021 May 7.
5
Monomeric Form of Peptidylarginine Deiminase Type I Revealed by X-ray Crystallography and Small-Angle X-ray Scattering.通过X射线晶体学和小角X射线散射揭示的I型肽基精氨酸脱亚氨酶的单体形式
J Mol Biol. 2016 Jul 31;428(15):3058-73. doi: 10.1016/j.jmb.2016.06.018. Epub 2016 Jul 5.
6
Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography.通过 X 射线晶体学对人肽基精氨酸脱亚氨酶 III 型进行结构表征。
Acta Crystallogr F Struct Biol Commun. 2021 Oct 1;77(Pt 10):334-340. doi: 10.1107/S2053230X21009195. Epub 2021 Sep 21.
7
Crystallization and preliminary X-ray crystallographic analysis of human myotubularin-related protein 1.人肌管素相关蛋白1的结晶及初步X射线晶体学分析
Acta Crystallogr F Struct Biol Commun. 2015 Mar;71(Pt 3):261-5. doi: 10.1107/S2053230X15000606. Epub 2015 Feb 19.
8
Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.使用 Cl-酰胺、PAD2、PAD3 和 PAD4 同工酶特异性抑制剂在胰腺癌细胞中应用肽基精氨酸脱亚氨酶抑制剂,揭示了 PAD2 和 PAD3 在癌症侵袭和细胞外囊泡特征调节中的作用。
Int J Mol Sci. 2021 Jan 30;22(3):1396. doi: 10.3390/ijms22031396.
9
Expression, crystallization and preliminary X-ray crystallographic studies of Arthrobacter globiformis inulin fructotransferase.球形节杆菌菊粉果糖转移酶的表达、结晶及初步X射线晶体学研究
Acta Crystallogr D Biol Crystallogr. 2003 Dec;59(Pt 12):2286-8. doi: 10.1107/s0907444903019140. Epub 2003 Nov 27.
10
Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.牙龈卟啉单胞菌肽基精氨酸脱亚氨酶底物特异性。
Anaerobe. 2013 Oct;23:102-8. doi: 10.1016/j.anaerobe.2013.07.001. Epub 2013 Jul 13.

引用本文的文献

1
Autocitrullination and Changes in the Activity of Peptidylarginine Deiminase 3 Induced by High Ca Concentrations.高钙浓度诱导的肽基精氨酸脱亚氨酶3的自身瓜氨酸化及活性变化
ACS Omega. 2022 Aug 8;7(32):28378-28387. doi: 10.1021/acsomega.2c02972. eCollection 2022 Aug 16.
2
Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography.通过 X 射线晶体学对人肽基精氨酸脱亚氨酶 III 型进行结构表征。
Acta Crystallogr F Struct Biol Commun. 2021 Oct 1;77(Pt 10):334-340. doi: 10.1107/S2053230X21009195. Epub 2021 Sep 21.
3
Histone citrullination: a new target for tumors.组蛋白瓜氨酸化:肿瘤的新靶点。
Mol Cancer. 2021 Jun 11;20(1):90. doi: 10.1186/s12943-021-01373-z.
4
Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type I.人I型肽基精氨酸脱亚氨酶的结晶及初步X射线晶体学分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Dec;69(Pt 12):1357-9. doi: 10.1107/S1744309113028704. Epub 2013 Nov 28.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
S100 and S100 fused-type protein families in epidermal maturation with special focus on S100A3 in mammalian hair cuticles.表皮成熟过程中的 S100 和 S100 融合蛋白家族,特别关注哺乳动物毛小皮中的 S100A3。
Biochimie. 2011 Dec;93(12):2038-47. doi: 10.1016/j.biochi.2011.05.028. Epub 2011 Jun 1.
3
Refined crystal structures of human Ca(2+)/Zn(2+)-binding S100A3 protein characterized by two disulfide bridges.经二硫键稳定的人源 Ca(2+)/Zn(2+)-结合 S100A3 蛋白的精细晶体结构。
J Mol Biol. 2011 May 6;408(3):477-90. doi: 10.1016/j.jmb.2011.02.055. Epub 2011 Mar 4.
4
Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.PAD1、3 和 4 的底物特异性和动力学研究鉴定出了蛋白精氨酸脱亚氨酶 3 的有效且选择性抑制剂。
Biochemistry. 2010 Jun 15;49(23):4852-63. doi: 10.1021/bi100363t.
5
Transcriptional regulation of peptidylarginine deiminase expression in human keratinocytes.人角质形成细胞中肽基精氨酸脱亚氨酶表达的转录调控
J Dermatol Sci. 2009 Jan;53(1):2-9. doi: 10.1016/j.jdermsci.2008.09.009. Epub 2008 Nov 11.
6
Specific citrullination causes assembly of a globular S100A3 homotetramer: a putative Ca2+ modulator matures human hair cuticle.特定的瓜氨酸化导致球状S100A3同四聚体的组装:一种假定的Ca2+调节剂使人类毛小皮成熟。
J Biol Chem. 2008 Feb 22;283(8):5004-13. doi: 10.1074/jbc.M709357200. Epub 2007 Dec 14.
7
Version 1.2 of the Crystallography and NMR system.晶体学与核磁共振系统1.2版本。
Nat Protoc. 2007;2(11):2728-33. doi: 10.1038/nprot.2007.406.
8
Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.人肽基精氨酸脱亚氨酶4识别组蛋白N端的结构基础
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5291-6. doi: 10.1073/pnas.0509639103. Epub 2006 Mar 27.
9
The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations.在人类表皮中表达的肽基精氨酸脱亚氨酶在底物特异性和亚细胞定位方面存在差异。
Cell Mol Life Sci. 2005 Sep;62(17):1984-95. doi: 10.1007/s00018-005-5196-y.
10
Peptidylarginine deiminase isoforms are differentially expressed in the anagen hair follicles and other human skin appendages.肽基精氨酸脱亚氨酶同工型在生长期毛囊和其他人类皮肤附属器中差异表达。
J Invest Dermatol. 2005 Jul;125(1):34-41. doi: 10.1111/j.0022-202X.2005.23763.x.

人Ⅲ型肽基精氨酸脱亚氨酶的结晶及初步X射线晶体学分析

Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type III.

作者信息

Unno Masaki, Kizawa Kenji, Ishihara Makiko, Takahara Hidenari

机构信息

Frontier Research Center for Applied Atomic Sciences, Ibaraki University, 162-1 Shirakata, Tokai, Naka, Ibaraki 319-1106, Japan.

出版信息

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Jun 1;68(Pt 6):668-70. doi: 10.1107/S1744309112015333. Epub 2012 May 23.

DOI:10.1107/S1744309112015333
PMID:22684066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3370906/
Abstract

In the presence of calcium ions, human peptidylarginine deiminase (PAD) converts arginine residues in proteins to citrulline. Of the five known human PAD enzymes, the type III isozyme (PAD3) exhibits the highest specificity for synthetic and natural substrates. This study aimed to determine the structure of PAD3 in order to elucidate its selective citrullination mechanism. Crystals of PAD3 obtained using polyethylene glycol 400 as a precipitant diffracted to 2.95 Å resolution using synchrotron radiation. They belonged to space group R3, with unit-cell parameters a = b = 114.97, c = 332.49 Å (hexagonal axes). Assuming two molecules were contained in an asymmetric unit, the calculated Matthews coefficient was 2.83 Å(3) Da(-1), corresponding to a solvent content of 56.6%. Initial phases were determined using PAD4 as a molecular-replacement model.

摘要

在钙离子存在的情况下,人肽基精氨酸脱氨酶(PAD)可将蛋白质中的精氨酸残基转化为瓜氨酸。在已知的五种人PAD酶中,III型同工酶(PAD3)对合成底物和天然底物表现出最高的特异性。本研究旨在确定PAD3的结构,以阐明其选择性瓜氨酸化机制。使用聚乙二醇400作为沉淀剂获得的PAD3晶体,利用同步辐射衍射至2.95 Å分辨率。它们属于空间群R3,晶胞参数a = b = 114.97,c = 332.49 Å(六方轴)。假设一个不对称单位中包含两个分子,计算得到的马修斯系数为2.83 Å(3) Da(-1),对应溶剂含量为56.6%。使用PAD4作为分子置换模型确定了初始相位。